MyBliss secures backing from women-led angel groups

MyBliss has secured investment from women-led angel groups to scale science-led intimacy care and women’s health research.

The company, founded after co-founder Mo Carrier’s experience with hormonal contraception side effects, centres products on women’s bodies and needs. Its flagship MyBliss Ultra-Thin Condoms were developed using gynaecologist-informed criteria and strict formulation standards.

The condoms are vegan-certified without casein or other animal derivatives, and free from glycerine, parabens, spermicide and fragrance, substances that can irritate or disrupt the vaginal microbiome. The vaginal microbiome is the community of helpful bacteria that supports pH balance and protects against infection. The condoms are ultra-thin, naturally lubricated and packaged in a discreet, ergonomic “buttercup” format for ease and hygiene.

MyBliss is working on a £100k Innovate UK-funded project with the University of Manchester to develop a condom designed to support the vaginal microbiome. The brand will also launch MyBliss Intimate Gel, a laboratory-developed, microbiome-conscious, hydrating formulation created with formulation scientists to support comfort and pH balance.

The round was led by Mint Ventures with co-investment from Alma Angels and Lifted Ventures.

Gillian Fleming, managing director of Mint Ventures, said: “We are thrilled to support My Bliss and their visionary team. Their commitment to improving women’s health through evidence-based innovation aligns perfectly with our mission to back diverse founders who are changing the world for the better. We believe My Bliss is poised to make a significant difference to women’s health, and we’re excited to be part of their journey.”

Mo Carrier, co-founder and chief executive of MyBliss, said: “Partnering with Mint Ventures marks an exciting new chapter for My Bliss. Their belief in our mission to transform women’s health is incredibly empowering, and their support will help us scale our impact and reach even more women seeking better, personalised wellbeing solutions.”

Helen Oldham and Jordan Dargue, co-founders of Lifted Ventures, said: “We are proud to co-invest in MyBliss, a female-led company redefining women’s sexual wellness with integrity, scientific rigour, and genuine purpose. For Lifted Ventures, supporting MyBliss means investing in women and in women’s health solutions shaped by women, for women.”

Roxanne Sanguinetti, founding partner of Alma Angels, said: “At Alma Angels we back women founders building products the world has been missing. MyBliss is exactly that. Mo and Joel are creating science-led intimacy care designed for women’s bodies first, with comfort and pleasure treated as part of health. We are proud our Angels have collaborated to invest alongside Mint Ventures and Lifted Ventures, and we’re excited to help MyBliss scale a category-changing brand.”

Mint Ventures and Lifted Ventures are supported by the British Business Bank.